Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: A two-year single-blind clinical trial

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Wang, Yuanyuan ^a   Hall, Stephen ^b   Hanna, Fahad ^a   Wluka, Anita E ^a   Grant, Gail ^b   Marks, Paul ^c   Feletar, Marie ^b   Cicuttini, Flavia M ^a  

^a MONASH UNIVERSITY   (Australia)

^b CABRINI INSTITUTE   (Australia)

^c Department of Radiology ^*  (Australia)

Author keywords

Cartilage; Hyaluronic acid; Hylan; Magnetic resonance imaging (MRI); Osteoarthritis

Indexed keywords

HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; BIOMATERIAL; DRUG DERIVATIVE; HYLAN;

ADULT; AGED; ARTICLE; BODY MASS; CARTILAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; SINGLE BLIND PROCEDURE; TIBIA; TISSUE PRESERVATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISCOSUPPLEMENTATION; ARTICULAR CARTILAGE; CLINICAL TRIAL; DRUG EFFECT; INTRAARTICULAR DRUG ADMINISTRATION; KNEE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

AGED; BIOCOMPATIBLE MATERIALS; CARTILAGE, ARTICULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PILOT PROJECTS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 80052035131     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-195     Document Type: Article

References (32)

1. Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Brooks PM, Curr Opin Rheumatol 2002 14 5 573 577 10.1097/00002281-200209000-00017 12192258 (Pubitemid 34953798)
2. An update on the pathogenesis and epidemiology of osteoarthritis. Felson DT, Radiol Clin North Am 2004 42 1 1 9 v 10.1016/S0033-8389(03)00161-1 15049520 (Pubitemid 38283553)
3. Rheological properties of synovial fluids. Fam H, Bryant JT, Kontopoulou M, Biorheology 2007 44 2 59 74 17538199 (Pubitemid 47356403)
4. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. Pelletier JP, Martel-Pelletier J, J Rheumatol Suppl 1993 39 19 24 8410880 (Pubitemid 23284289)
5. Treating knee osteoarthritis with intra-articular hyaluronans. Brzusek D, Petron D, Curr Med Res Opin 2008 24 12 3307 3322 10.1185/03007990802490124 18954498
6. Viscosupplementation for the treatment of osteoarthritis of the knee. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G, Cochrane Database Syst Rev 2006 2 D005321
7. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Takahashi K, Goomer RS, Harwood F, Kubo T, Hirasawa Y, Amiel D, Osteoarthritis Cartilage 1999 7 2 182 190 10.1053/joca.1998.0207 10222217 (Pubitemid 29219664)
8. Intra-articular hyaluronate in experimental rabbit osteoarthritis can prevent changes in cartilage proteoglycan content. Hulmes DJ, Marsden ME, Strachan RK, Harvey RE, McInnes N, Gardner DL, Osteoarthritis Cartilage 2004 12 3 232 238 10.1016/j.joca.2003.11.007 14972340 (Pubitemid 38248072)
9. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis. Marshall KW, Manolopoulos V, Mancer K, Staples J, Damyanovich A, J Orthop Res 2000 18 3 416 425 10.1002/jor.1100180313 10937628 (Pubitemid 30599617)
10. Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy. Smith MM, Cake MA, Ghosh P, Schiavinato A, Read RA, Little CB, Rheumatology (Oxford) 2008 47 8 1172 1178 10.1093/rheumatology/ken219 (Pubitemid 352038222)
11. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Frizziero L, Govoni E, Bacchini P, Clin Exp Rheumatol 1998 16 4 441 449 9706425 (Pubitemid 28370856)
12. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Pasquali Ronchetti I, Guerra D, Taparelli F, Boraldi F, Bergamini G, Mori G, Zizzi F, Frizziero L, Rheumatology (Oxford) 2001 40 2 158 169 10.1093/rheumatology/40.2.158
13. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Guidolin DD, Ronchetti IP, Lini E, Guerra D, Frizziero L, Osteoarthritis Cartilage 2001 9 4 371 381 10.1053/joca.2000.0398 11399102 (Pubitemid 32454781)
14. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, Dougados M, Osteoarthritis Cartilage 1997 5 3 153 160 10.1016/S1063-4584(97)80010-6 9219678 (Pubitemid 27261990)
15. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P, Int J Clin Pract 2003 57 6 467 474 12918884 (Pubitemid 36974884)
16. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Cubukcu D, Ardic F, Karabulut N, Topuz O, Clin Rheumatol 2005 24 4 336 341 10.1007/s10067-004-1043-z 15599642 (Pubitemid 41102429)
17. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al. Arthritis Rheum 1986 29 8 1039 1049 10.1002/art. 1780290816 3741515
18. Atlas of standard radiographs. Kellgren JH, Lawrence JS, The epidemiology of chronic rheumatism; a symposium organized by the Council for International Organizations of Medical Science Oxford. Blackwell Scientific Publications, Kellgren JH, 1963 2 21834914
19. How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Wluka AE, Wolfe R, Stuckey S, Cicuttini FM, Ann Rheum Dis 2004 63 3 264 268 10.1136/ard/2003.007666 14962960 (Pubitemid 38250668)
20. Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. Ding C, Garnero P, Cicuttini F, Scott F, Cooley H, Jones G, Osteoarthritis Cartilage 2005 13 3 198 205 10.1016/j.joca.2004.11.007 15727885 (Pubitemid 40277277)
21. Bone marrow edema and its relation to progression of knee osteoarthritis. Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, Li W, Hill C, Gale D, Ann Intern Med 2003 139 5 Pt 1 330 336 12965941
22. The determinants of change in tibial cartilage volume in osteoarthritic knees. Wluka AE, Stuckey S, Snaddon J, Cicuttini FM, Arthritis Rheum 2002 46 8 2065 2072 10.1002/art.10460 12209510
23. Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Jones G, Ding C, Scott F, Glisson M, Cicuttini F, Osteoarthritis Cartilage 2004 12 2 169 174 10.1016/j.joca.2003.08.010 14723876 (Pubitemid 38181124)
24. Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study. Cicuttini FM, Jones G, Forbes A, Wluka AE, Ann Rheum Dis 2004 63 9 1124 1127 10.1136/ard.2004.021253 15115714 (Pubitemid 39120365)
25. Association of prevalent and incident knee cartilage defects with loss of tibial and patellar cartilage: a longitudinal study. Ding C, Cicuttini F, Scott F, Boon C, Jones G, Arthritis Rheum 2005 52 12 3918 3927 10.1002/art.21474 16320339 (Pubitemid 41798231)
26. The clinical correlates of articular cartilage defects in symptomatic knee osteoarthritis: a prospective study. Wluka AE, Ding C, Jones G, Cicuttini FM, Rheumatology (Oxford) 2005 44 10 1311 1316 10.1093/rheumatology/kei018 (Pubitemid 41487968)
27. Interaction between active and passive knee stabilizers during level walking. Schipplein OD, Andriacchi TP, J Orthop Res 1991 9 1 113 119 10.1002/jor.1100090114 1984041
28. Abnormal and cumulative loading in knee osteoarthritis. Maly MR, Curr Opin Rheumatol 2008 20 5 547 552 10.1097/BOR.0b013e328307f58c 18698176
29. Sodium hyaluronate therapy in osteoarthritis: arguments for a potential beneficial structural effect. Dougados M, Semin Arthritis Rheum 2000 30 2 Suppl 1 19 25 11071578
30. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Moreland LW, Arthritis Res Ther 2003 5 2 54 67 10.1186/ar623 12718745 (Pubitemid 36849751)
31. Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis. Conrozier T, Chevalier X, Expert Opin Pharmacother 2008 9 10 1797 1804 10.1517/14656566.9.10.1797 18570611
32. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Raynauld JP, Goldsmith CH, Bellamy N, Torrance GW, Polisson R, Belovich D, Pericak D, Tugwell P, Osteoarthritis Cartilage 2005 13 2 111 119 10.1016/j.joca.2004.10.018 15694572 (Pubitemid 40220801)